Technical Analysis The stock is showing positive momentum with RSI at 69.24, indicating strong but not yet overbought conditions. Currently trading at $88.67, the price is above its 20-day moving average of $83.24, suggesting a bullish short-term trend.

Recent Analyst Actions Jefferies recently upgraded GEHC to Strong Buy from Hold on January 8, 2025, raising the price target to $103 from $95, suggesting a 19.41% upside potential. The upgrade was based on:

Stock trading at attractive 17-18x 2025 earnings
Below peer average valuations
Strong market positioning in diagnostic imaging

Market Sentiment Recent market data shows positive momentum with:

Regular market change: +0.58%
Post-market change: +0.01%
Trading volume: 2.01M shares

Fibonacci Levels Current key levels:

Resistance: R1 at $88.11, R2 at $89.51
Support: S1 at $83.59, S2 at $82.19
Pivot: $85.85

Based on the technical and fundamental analysis, GEHC appears to be in a favorable position for buying at current levels. The stock has strong analyst support, positive momentum, and is trading below recent price targets while maintaining healthy technical indicators.

What is price prediction 2025 for GEHC Stock?

Based on the provided data and recent analyst reports, here is the price prediction for GEHC stock in 2025:

GE Healthcare (GEHC) stock is expected to reach $103 by end of 2025, driven by its renewed focus on AI-enabled medical devices and margin expansion through differential organic and inorganic investment. The company's strong execution in a healthy market environment combined with new product launches in pharmaceutical diagnostics and imaging could lead to earnings beats and multiple expansion. However, ongoing challenges in the Chinese market, which represents about 12% of sales, pose some uncertainty to this target.

What is surpport and resistant level for GEHC Stock?

The S1 support level for GEHC Stock is $83.59 ,The R1 resistant level for GEHC Stock is $88.11.

What is the current price of GEHC Stock?

As of the end of day on 2025-01-24, the price of GEHC Stock was $88.67.

What is the target price of GEHC Stock?

The target price for GEHC Stock according to analyst rating is 98.45, with the highest price target at 105.00 and the lowest at 86.00. Analysts have a Strong Buy rating on GEHC Stock overall.

What is the market cap of GE Healthcare Technologies Inc?

The market cap of GEHC is $40.5B.

Is GE Healthcare Technologies Inc (GEHC) overvalued?

Based on the provided data and recent market developments, here's a concise analysis of GEHC's valuation:

Valuation Analysis: GEHC currently trades at a P/E of 25.7x, EV/EBITDA of 14.2x, and P/S of 2.2x as of Q3 2024, indicating relatively high multiples compared to historical levels from earlier quarters.

Recent Performance: The stock closed at $88.67 on January 24, 2025, with a modest gain of 0.58% during regular trading hours .

Key Concerns:

Recent earnings misses have raised concerns about consistency in execution
Chinese market weakness with 22% decline in sales, representing 11.6% of overall revenue
CEO Jim Cramer is "rethinking his stance" due to questions about digital machine leadership and repeated earnings misses

Positive Factors:

Jefferies recently upgraded GEHC to "buy" with a $103 price target, citing strong execution and healthy market environment
Company has 81 FDA-approved AI-enabled devices, leading the industry
Potential recovery in Chinese market expected later in 2025

Conclusion: GEHC appears overvalued at current levels given its operational challenges, particularly in China, and inconsistent earnings performance. The high valuation multiples don't provide sufficient margin of safety considering these headwinds.

What is GE Healthcare Technologies Inc (GEHC)'s business?

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

What is price prediction 2030 for GEHC Stock?

Based on the provided data and market analysis, here is a prediction for GEHC stock price by 2030:

GE Healthcare (GEHC) stock is projected to reach $165-175 by 2030, driven by its expanding AI-enabled medical devices portfolio and strong market positioning in diagnostic imaging. The company's focus on operational efficiency and growing recurring revenue from 45% to 60% of total sales supports this bullish outlook. The recent upgrade by Jefferies with a $103 price target for near-term already indicates strong growth momentum.